• DENENICOKIN chembl:CHEMBL2107855 Antineoplastic

    Alternate Names:

    RECOMBINANT HUMAN INTERLEUKIN 21
    BMS-982470
    IL-21 RECOMBINANT
    RIL-21; RECOMBINANT HUMAN INTERLEUKIN 21
    DENENICOKIN
    RIL-21
    IL-21

    Drug Info:

    FDA Approval not approved
    Drug Class recombinant protein
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 30.91

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name Denenicokin
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 15.46

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class recombinant protein
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D07JWO TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: